
Fulgent Genetics, Inc.
FLGTNASDAQHealthcareDiagnostics & Research
As of Oct 22, 2026 close
- Market cap
- $559.82M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $13.46$31.04
- Volume (live)
- -
- Avg. volume (3M)
- 305.84K
Fulgent Genetics (FLGT) Stock Price & Financial Analysis
Fulgent Genetics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $19.30 - $20.24 |
|---|---|
| 52-Week High | $31.04 |
| 52-Week Low | $13.46 |
| Open | $20.08 |
| Volume (last close) | 278.88K |
| Average Volume (3M) | 305.84K |
| Revenue (TTM) | 323.93M |
|---|---|
| Net Income (TTM) | -84.38M |
| Free Cash Flow (TTM) | -103.79M |
| EPS (TTM) | −$2.80 |
| Profit Margin | -26.05% |
| Operating Margin | -37.75% |
| Return on Equity (ROE) | -8.47% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 559.82M |
|---|---|
| Shares Outstanding | 28.00M |
| Price to Sales (P/S) | 1.73 |
| Price to Book (P/B) | 0.56 |
| EV/EBITDA | -6.85 |
| 50-Day MA | $20.51 |
|---|---|
| 200-Day MA | $19.65 |
| 1-Year Change | −15.37% |
Source: Market prices and company fundamentals. Data as of Oct 22, 2026. Data sources and methodology
Fulgent Genetics at a Glance
As of the Oct 22, 2026 close, Fulgent Genetics (FLGT) has a market capitalization of $559.82M. The stock trades at 1.7× sales. Over the trailing twelve months it lost $84.38M on revenue of $323.93M and burned $103.79M of free cash flow. Revenue grew 6.8% year over year.
As of its latest reported balance sheet, it holds $26.30M in cash and securities against $1.96M of debt, a net cash position of $24.35M.
Fulgent Genetics does not currently pay a dividend.
The share price is down 15.4% over the past year. At $19.99 (the Oct 22, 2026 close) it sits within its 52-week range of $13.46 to $31.04, above its 200-day moving average of $19.65.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Fulgent Genetics
What is the current stock price for FLGT?
As of the Oct 22, 2026 close, FLGT stock trades at $19.99. The 52-week range is $13.46–$31.04, with a day range of $19.30–$20.24.
What is the P/E ratio for FLGT?
The P/E ratio (Price-to-Earnings) for FLGT is shown in the Key Statistics section. This valuation metric helps compare Fulgent Genetics, Inc. to industry peers.
Does FLGT pay dividends?
Fulgent Genetics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for FLGT?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for FLGT is Buy.
What is the market cap of FLGT?
As of the Oct 22, 2026 close, Fulgent Genetics's market capitalization is $559.8M, classifying it as a small-cap company. Fulgent Genetics operates in the Healthcare sector within the Diagnostics & Research industry.